Literature DB >> 10898422

Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function.

S Yasuda1, Y Goto, T Baba, T Satoh, H Sumida, S Miyazaki, H Nonogi.   

Abstract

OBJECTIVES: We hypothesized that the hepatocyte growth factor (HGF) may play a cardioprotective role in human myocardial infarction (MI).
BACKGROUND: The HGF is a novel, multifunctional growth factor implicated in wound healing, angiogenesis and promotion of cell survival. Recent animal studies have demonstrated the existence of an HGF system in the heart, where it is activated in response to myocardial ischemia and reperfusion.
METHODS: We studied 40 patients with acute myocardial infarction (AMI), who underwent coronary reperfusion therapy upon admission. Approximately four weeks later, left ventricular (LV) catheterization was repeated to determine the LV ejection fraction (EF), end-diastolic volume index (EDVI) and pressure (EDP). The levels of HGF and brain natriuretic peptide (BNP) were measured by collecting blood samples from cardiac veins draining the infarcted region (MI region) and those draining the noninfarcted region (non-MI region). The ratio of the HGF level in the MI region to that in the non-MI region (= MI/non-MI ratio) was calculated in each patient as an index of the MI-related HGF secretion. The MI/non-MI ratio for BNP was also calculated.
RESULTS: The MI/non-MI ratio for HGF correlated inversely with LVEDP (r = -0.644, p < 0.0001) and LVEDVI (r = -0.843, p < 0.0001) and positively with LVEF (r = 0.763, p < 0.0001). These correlations were completely opposite in direction from those for BNP and LVEDP (r = 0.678, p < 0.0001), LVEDVI (r = 0.783, p < 0.0001) and LVEF (r = -0.805, p < 0.0001). These findings indicate that cardiac HGF acts in contrast to BNP, a biochemical marker for the development of LV remodeling.
CONCLUSIONS: Enhanced secretion of cardiac HGF from the MI region is associated with an attenuation of ventricular enlargement and an improvement in cardiac function. The HGF system may modulate the process of ventricular remodeling and thus have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898422     DOI: 10.1016/s0735-1097(00)00675-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

Review 1.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

2.  shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair.

Authors:  Ivana Rosová; Daniel Link; Jan A Nolta
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

3.  Endothelial Grb2-associated binder 1 is crucial for postnatal angiogenesis.

Authors:  Jinjing Zhao; Weiye Wang; Chang Hoon Ha; Ji Young Kim; Chelsea Wong; Eileen M Redmond; Anne Hamik; Mukesh K Jain; Gen-Sheng Feng; Zheng Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-03       Impact factor: 8.311

Review 4.  Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease.

Authors:  Nirat Beohar; Jonathan Rapp; Sanjay Pandya; Douglas W Losordo
Journal:  J Am Coll Cardiol       Date:  2010-10-12       Impact factor: 24.094

5.  Myocardial transfection with naked DNA plasmid encoding hepatocyte growth factor prevents the progression of heart failure in dogs.

Authors:  Sharad Rastogi; Mayra Guerrero; Mengjun Wang; Itamar Ilsar; Michael S Sabbah; Ramesh C Gupta; Hani N Sabbah
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-07       Impact factor: 4.733

6.  Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor.

Authors:  María-Consuelo Pintado; Lara Maceda; María Trascasa; Ignacio Arribas; Raúl De Pablo
Journal:  Egypt Heart J       Date:  2022-04-28

7.  MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium.

Authors:  Maythem Saeed; Alastair Martin; Phillip Ursell; Loi Do; Matt Bucknor; Charles B Higgins; David Saloner
Journal:  Radiology       Date:  2008-08-05       Impact factor: 11.105

8.  Activation of Notch-mediated protective signaling in the myocardium.

Authors:  Natalie A Gude; Gregory Emmanuel; Weitao Wu; Christopher T Cottage; Kimberlee Fischer; Pearl Quijada; John A Muraski; Roberto Alvarez; Marta Rubio; Eric Schaefer; Mark A Sussman
Journal:  Circ Res       Date:  2008-03-27       Impact factor: 17.367

9.  Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.

Authors:  Ivana Rosová; Mo Dao; Ben Capoccia; Daniel Link; Jan A Nolta
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

Review 10.  Contribution of human hematopoietic stem cells to liver repair.

Authors:  Ping Zhou; Louisa Wirthlin; Jeannine McGee; Geralyn Annett; Jan Nolta
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.